Outcome measures in muscular dystrophy rehabilitation: an ICF content comparison approach to the most commonly used MD scales

Authors

  • Mihaela Taranu Physical Medicine and Rehabilitation Department, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain; WHOFIC Academic Collaborating Center- Univesitat de Barcelona, Barcelona, Spain
  • Raquel Sebio-García Physical Medicine and Rehabilitation Department, Hospital Germans Trias I Pujol, Badalona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) University of Barcelona, Barcelona, Spain
  • José C. Milisenda scle Research Unit, Internal Medicine Service, Hospital Clínic de Barcelona (HCB), Universidad de Barcelona and Center for Biomedical Research on Rare Diseases (CIBERER), Barcelona, Spain
  • Aida Alejaldre Neurology Service, Hospital Clinic, Barcelona, Spain
  • Xavier Pastor WHOFIC Academic Collaborating Center-Universitat de Barcelona, Barcelona; Clinical Informatics, Hospital Clínic – Universitat de Barcelona, Barcelona, Spain
  • Sarah Laxe WHOFIC Academic Collaborating Center- Univesitat de Barcelona, Barcelona, Spain; August Pi i Sunyer Biomedical Research Institute (IDIBAPS) University of Barcelona, Barcelona, Spain; Physical and Rehabilitation Department, Hospital Clinic, ICEMEQ, Barcelona, Spain; Clinical and Experimental Respiratory Immunoallergy (IRCE), Clinic Foundation for Biomedical Research, Barcelona, Spain

DOI:

https://doi.org/10.2340/jrm.v57.40327

Keywords:

muscular dystrophy, outcome measures, international classification of functioning, functional status

Abstract

Introduction: Functioning is the reason to be of rehabilitation as it is essential to the lives of people who suffer from a disease. The International Classification of Functioning, Disability and Health (ICF) can help in designing a functioning profile of a patient, identifying needs for rehabilitation plans and measuring the results of an intervention.

Objective: To identify the outcome measurement instruments reported in clinical studies in muscular dystrophies (MDs) and provide an ICF content analysis.

Method: A systematic literature review was conducted until October 2022, using Medline, PubMed, and Scopus databases. Papers assessing outcomes related to functioning in patients with MDs were included.

Results: A total of 116 papers were included and all identified outcome measures were linked to the ICF. Inter-researcher agreement for the linking process was 0.82. The analysed instruments focused mainly on aspects of body functions, followed by activities and participation. General scales were more comprehensive than specific.

Conclusions: The application of ICF in this research enhances the understanding of functioning of patients with MDs and the need to develop more specific but comprehensive scales tailored to the needs of MD patients, and can guide clinicians in a assessing patients through a biopsychosocial perspective.

Downloads

Download data is not yet available.

References

Mercuri E., Muntoni F. Muscular dystrophies. Lancet 2013; 381: 8 45-860.

https://doi.org/10.1016/S0140-6736(12)61897-2 DOI: https://doi.org/10.1016/S0140-6736(12)61897-2

Lindsay S, Cagliostro E, McAdam L. Meaningful occupations of young adults with muscular dystrophy and other neuromuscular disorders. Can J Occup Ther 2019; 86: 277-288.

https://doi.org/10.1177/0008417419832466 DOI: https://doi.org/10.1177/0008417419832466

Minis MA, Satink T, Kinébanian A, Engels JA, Heerkens YF, van Engelen BG, et al. How persons with a neuromuscular disease perceive employment participation: a qualitative study. J Occup Rehabil 2014; 24: 52-67.

https://doi.org/10.1007/s10926-013-9447-8 DOI: https://doi.org/10.1007/s10926-013-9447-8

Llamosas-Falcón L, Sánchez-Díaz G, Gallego E, Villaverde-Hueso A, Arias-Merino G, Posada de la Paz M, et al. A population-based study of mortality due to muscular dystrophies across a 36-year period in Spain. Sci Rep. 2022: 8; 12(1): 3750.

https://doi.org/10.1038/s41598-022-07814-z DOI: https://doi.org/10.1038/s41598-022-07814-z

Natera-de Benito D, Foley AR, Domínguez-González C, Ortez C, Jain M, Mebrahtu A, et al. Association of initial maximal motor ability with long-term functional outcome in patients with COL6-related dystrophies. Neurology 2021; 96: e1413-1424.

https://doi.org/10.1212/WNL.0000000000011499 DOI: https://doi.org/10.1212/WNL.0000000000011499

Grisbrook TL, Stearne SM, Reid SL, Wood FM, Rea SM, Elliott CM. Demonstration of the use of the ICF framework in detailing complex functional deficits after major burn. Burns J Int Soc Burn Inj. 2012; 38(1): 32-43.

https://doi.org/10.1016/j.burns.2011.04.001 DOI: https://doi.org/10.1016/j.burns.2011.04.001

Cieza A, Boldt C, Ballert CS, Eriks-Hoogland I, Bickenbach JE, Stucki G. Setting up a cohort study on functioning: deciding what to measure. Am J Phys Med Rehabil Assoc Acad Physiatr 2011; 90: S17-28.

https://doi.org/10.1097/PHM.0b013e318230fddb DOI: https://doi.org/10.1097/PHM.0b013e318230fddb

Crawford L, Maxwell J, Colquhoun H, Kingsnorth S, Fehlings D, Zarshenas S, et al. Facilitators and barriers to patient-centred goal-setting in rehabilitation: A scoping review. Clin Rehabil 2022; 36: 1694-1704.

https://doi.org/10.1177/02692155221121006 DOI: https://doi.org/10.1177/02692155221121006

Cieza A, Kwamie A, Magaqa Q, Paichadze N, Sabariego C, Blanchet K, et al. Framing rehabilitation through health policy and systems research: priorities for strengthening rehabilitation. Health Res Policy Syst 2022; 20: 101.

https://doi.org/10.1186/s12961-022-00903-5 DOI: https://doi.org/10.1186/s12961-022-00903-5

Alford VM, Ewen S, Webb GR, McGinley J, Brookes A, Remedios LJ. The use of the International Classification of Functioning, Disability and Health to understand the health and functioning experiences of people with chronic conditions from the person perspective: a systematic review. Disabil Rehabil 2015; 37: 655-666.

https://doi.org/10.3109/09638288.2014.935875 DOI: https://doi.org/10.3109/09638288.2014.935875

Leonardi M, Lee H, Kostanjsek N, Fornari A, Raggi A, Martinuzzi A, et al. 20 Years of ICF-international classification of functioning, disability and health: uses and applications around the world. Int J Environ Res Public Health 2022; 19: 11321.

https://doi.org/10.3390/ijerph191811321 DOI: https://doi.org/10.3390/ijerph191811321

Kiekens C, Meyer T, Gimigliano F, Baffone C, Gutenbrunner CM; UEMS PRM ICF Workshop moderators and rapporteurs. European initiative for the application of the International Classification of Service Organization in Health-related Rehabilitation (ICSO-R). Eur J Phys Rehabil Med 2017; 53: 308-318.

https://doi.org/10.23736/S1973-9087.16.04437-3 DOI: https://doi.org/10.23736/S1973-9087.16.04437-3

Karlsson E, Gustafsson J. Validation of the International Classification of Functioning, Disability and Health (ICF) core sets from 2001 to 2019 - a scoping review. Disabil Rehabil 2022; 44: 3736-3748.

https://doi.org/10.1080/09638288.2021.1878562 DOI: https://doi.org/10.1080/09638288.2021.1878562

Laxe S, Cieza A, Castaño-Monsalve B. Rehabilitation of traumatic brain injury in the light of the ICF. NeuroRehabilitation 2015; 36: 37-43.

https://doi.org/10.3233/NRE-141189 DOI: https://doi.org/10.3233/NRE-141189

Package of interventions for rehabilitation. Module 3. Neurological conditions. Geneva: World Health Organization; 2023 (Package of interventions for rehabilitation). Licence: CC BY-NC-SA 3.0 IGO. Available from: http: //apps.who.int/iris.

Brach M, Cieza A, Stucki G, Füssl M, Cole A, Ellerin B, et al. ICF Core Sets for breast cancer. J Rehabil Med Off J UEMS Eur Board Phys Rehabil Med 2004; Suppl 44: 121-127.

https://doi.org/10.1080/16501960410016811 DOI: https://doi.org/10.1080/16501960410016811

Cieza A, Kirchberger I, Biering-Sørensen F, Baumberger M, Charlifue S, Post MW, et al. ICF Core Sets for individuals with spinal cord injury in the long-term context. Spinal Cord 2010; 48: 305-312.

https://doi.org/10.1038/sc.2009.183 DOI: https://doi.org/10.1038/sc.2009.183

Laxe S, Zasler N, Selb M, Tate R, Tormos JM, Bernabeu M. Development of the International Classification of Functioning, Disability and Health core sets for traumatic brain injury: an International consensus process. Brain Inj 2013; 27: 379-387.

https://doi.org/10.3109/02699052.2012.750757 DOI: https://doi.org/10.3109/02699052.2012.750757

Selb M, Gimigliano F, Prodinger B, Stucki G, Pestelli G, Iocco M, et al. Toward an International Classification of Functioning, Disability and Health clinical data collection tool: the Italian experience of developing simple, intuitive descriptions of the Rehabilitation Set categories. Eur J Phys Rehabil Med 2017; 53: 290-298.

https://doi.org/10.23736/S1973-9087.16.04250-7 DOI: https://doi.org/10.23736/S1973-9087.16.04250-7

Cieza A, Geyh S, Chatterji S, Kostanjsek N, Ustün B, Stucki G. ICF linking rules: an update based on lessons learned. J Rehabil Med Off J UEMS Eur Board Phys Rehabil Med 2005; 37: 212-218.

https://doi.org/10.1080/16501970510040263 DOI: https://doi.org/10.1080/16501970510040263

Ghasemi M, Emerson CP, Hayward LJ. Outcome measures in facioscapulohumeral muscular dystrophy clinical trials. Cells 2022; 11: 687.

https://doi.org/10.3390/cells11040687 DOI: https://doi.org/10.3390/cells11040687

Hermans MCE, Faber CG, De Baets MH, de Die-Smulders CEM, Merkies ISJ. Rasch-built myotonic dystrophy type 1 activity and participation scale (DM1-Activ). Neuromuscul Disord NMD 2010; 20: 310-318.

https://doi.org/10.1016/j.nmd.2010.03.010 DOI: https://doi.org/10.1016/j.nmd.2010.03.010

Endo M, Odaira, K, Ono R, Kurauchi G, Koseki A, Goto M, et al. Health-related quality of life and its correlates in Japanese patients with myotonic dystrophy type 1. Neuropsychiatr Dis Treat 2019; 15: 219-226.

https://doi.org/10.2147/NDT.S187607 DOI: https://doi.org/10.2147/NDT.S187607

Seesing FM, van Vught LE, Rose MR, Drost G, van Engelen BGM, van der Wilt GJ. The individualized neuromuscular quality of life questionnaire: cultural translation and psychometric validation for the Dutch population. Muscle Nerve 2015; 51: 496-500.

https://doi.org/10.1002/mus.24337 DOI: https://doi.org/10.1002/mus.24337

Fossmo HL, Ørstavik K, Frich JC, Robinson HS. Translation, reliability, and validity of the Norwegian version of the ABILHAND-NMD and the ACTIVLIM for Myotonic Dystrophy type 1. Disabil Rehabil 2024; 46: 2699-2707.

https://doi.org/10.1080/09638288.2023.2231848 DOI: https://doi.org/10.1080/09638288.2023.2231848

Laxe S, Tschiesner U, Zasler N, López-Blazquez R, Tormos JM, Bernabeu M. What domains of the International Classification of Functioning, Disability and Health are covered by the most commonly used measurement instruments in traumatic brain injury research? Clin Neurol Neurosurg 2012; 114: 645-650.

https://doi.org/10.1016/j.clineuro.2011.12.038 DOI: https://doi.org/10.1016/j.clineuro.2011.12.038

Bos I, Stallinga HA, Middel B, Kuks JB, Wynia K. Validation of the ICF core set for neuromuscular diseases. Eur J Phys Rehabil Med 2013; 49: 179-187.

Kroon RHMJM, Horlings CGC, de Swart BJM, van Engelen BGM, Kalf JG. Swallowing, chewing and speaking: frequently impaired in oculopharyngeal muscular dystrophy. J Neuromuscul Dis 2020; 7: 483-494

https://doi.org/10.3233/JND-200511 DOI: https://doi.org/10.3233/JND-200511

Mul K, Berggren KN, Sills MY, McCalley A, van Engelen BGM, Johnson NE, et al. Effects of weakness of orofacial muscles on swallowing and communication in FSHD. Neurology 2019; 92: e957-63.

https://doi.org/10.1212/WNL.0000000000007013 DOI: https://doi.org/10.1212/WNL.0000000000007013

Yamada Y, Kawakami M., Wada A., Fukui S., Haruyama K., Otsuka T.et al., Long-term follow-up of dysphagia in adult patients with Duchenne muscular dystrophy, European Journal of Paediatric Neurology 2018, 786-790.

https://doi.org/10.1016/j.ejpn.2018.06.004 DOI: https://doi.org/10.1016/j.ejpn.2018.06.004

Heller SA, Shih R, Kalra R, Kang PB. Emery-Dreifuss muscular dystrophy. Muscle Nerve 2020; 61: 436-448.

https://doi.org/10.1002/mus.26782 DOI: https://doi.org/10.1002/mus.26782

Hijikata N, Kawakami M, Wada A, Ikezawa M, Kaji K, Chiba Y, et al. Assessment of dysarthria with Frenchay dysarthria assessment (FDA-2) in patients with Duchenne muscular dystrophy. Disabil Rehabil 2022; 44: 1443-1450.

https://doi.org/10.1080/09638288.2020.1800108 DOI: https://doi.org/10.1080/09638288.2020.1800108

Koeks Z, Hellebrekers DMJ, van de Velde NM, Alleman I, Spitali P, van Duyvenvoorde HA, et al. The neurocognitive profile of adults with Becker muscular dystrophy in the Netherlands. J Neuromuscul Dis 2022; 9: 543-553.

https://doi.org/10.3233/JND-210770 DOI: https://doi.org/10.3233/JND-210770

Labayru G, Camino B, Jimenez-Marin A, Garmendia J, Villanua J, Zulaica M, et al. White matter integrity changes and neurocognitive functioning in adult-late onset DM1: a follow-up DTI study. Sci Rep 2022; 12: 3988.

https://doi.org/10.1038/s41598-022-07820-1 DOI: https://doi.org/10.1038/s41598-022-07820-1

Preethish-Kumar V, Shah A, Polavarapu K, Kumar M, Safai A, Vengalil S, et al. Disrupted structural connectome and neurocognitive functions in Duchenne muscular dystrophy: classifying and subtyping based on Dp140 dystrophin isoform. J Neurol 2022; 269: 2113-2125.

https://doi.org/10.1007/s00415-021-10789-y DOI: https://doi.org/10.1007/s00415-021-10789-y

Koscik TR, van der Plas E, Long JD, Cross S, Gutmann L, Cumming SA, et al. Longitudinal changes in white matter as measured with diffusion tensor imaging in adult-onset myotonic dystrophy type 1. Neuromuscul Disord NMD 2023; 33: 660-669.

https://doi.org/10.1016/j.nmd.2023.05.010 DOI: https://doi.org/10.1016/j.nmd.2023.05.010

O'Dowd DN, Bostock EL, Smith D, Morse CI, Orme P, Payton CJ. The effects of 12 weeks' resistance training on psychological parameters and quality of life in adults with Facioscapulohumeral, Becker, and Limb-girdle dystrophies. Disabil Rehabil 2022; 44: 5950-5956.

https://doi.org/10.1080/09638288.2021.1955306 DOI: https://doi.org/10.1080/09638288.2021.1955306

Hortas ML, Castilla JA, Gil MT, Molina J, Garrido ML, Morell M, et al. Decreased sperm function of patients with myotonic muscular dystrophy. Hum Reprod Oxf Engl 2000; 15: 445-448.

https://doi.org/10.1093/humrep/15.2.445 DOI: https://doi.org/10.1093/humrep/15.2.445

Parmova O, Vlckova E, Hulova M, Mensova L, Crha I, Stradalova P, et al. Anti-Müllerian hormone as an ovarian reserve marker in women with the most frequent muscular dystrophies. Medicine (Baltimore) 2020; 99: e20523.

https://doi.org/10.1097/MD.0000000000020523 DOI: https://doi.org/10.1097/MD.0000000000020523

Schofield C, Evans K, Young H, Paguinto SG, Carroll K, Townsend E, et al. The development of a consensus statement for the prescription of powered wheelchair standing devices in Duchenne muscular dystrophy. Disabil Rehabil 2022; 44: 1889-1897.

https://doi.org/10.1080/09638288.2020.1810786 DOI: https://doi.org/10.1080/09638288.2020.1810786

Lobo-Prat J, Enkaoua A, Rodríguez-Fernández A, Sharifrazi N, Medina-Cantillo J, Font-Llagunes JM, et al. Evaluation of an exercise-enabling control interface for powered wheelchair users: a feasibility study with Duchenne muscular dystrophy. J Neuroengineering Rehabil 2020; 17: 142.

https://doi.org/10.1186/s12984-020-00760-9 DOI: https://doi.org/10.1186/s12984-020-00760-9

Downloads

Published

2025-01-31

How to Cite

Taranu, M., Sebio-García, R., Milisenda, J. C., Alejaldre, A., Pastor, X., & Laxe, S. (2025). Outcome measures in muscular dystrophy rehabilitation: an ICF content comparison approach to the most commonly used MD scales. Journal of Rehabilitation Medicine, 57, jrm40327. https://doi.org/10.2340/jrm.v57.40327

Issue

Section

Original Report

Categories